America's Health Insurance Plans (AHIP)

Mark Ganz, president and CEO of Cambia Health Solutions, a not-for-profit parent of 22 companies offering healthcare products and services, discusses how his companies are seeking to make healthcare more consumer-directed.

Insurers are under fire for giving consumers bad information about which providers are in their plan network. The controversy raises a simple question: Is it really so hard to maintain an accurate provider directory?

How much does it cost to get a drug approved? A new estimate puts the number at $2.55 billion, more than twice the cost assessed by the same lead researcher a decade ago. Not everyone believes the math.

A big fight could be brewing over Obamacare's risk-corridor program. Insurers are relying on the program to protect them from major losses if their exchange customers end up being sicker and more costly than anticipated. But Republicans—most notably Sen. Marco Rubio (R-Fla.), a likely 2016...

A second potential blockbuster drug from Gilead Sciences to treat hepatitis C has been approved by the FDA. But at a cost of nearly $100,000 for a full course of treatment, it is certain to spark further debate over the pricing of specialty drugs.

Nearly 17.4 million Americans participate in health savings account-eligible insurance plans, a decade after Congress authorized the creation of health savings accounts, according to results of a census released this week by industry trade group America's Health Insurance Plans.